A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease

Journal of Clinical Nursing

Volumn 16, Issue 8, 2007, Pages 1427-1434

  Holbrook, Karen ^a  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Adverse reactions; Azathioprine and 6 mercaptopurine; Inflammatory bowel disease; Knowledge and information; Nurse specialist; Shared care

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG ADMINISTRATION; DRUG MONITORING; DRUG USE; ENTERITIS; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HUMAN; MEDICAL STAFF; METHODOLOGY; NURSE; NURSING METHODOLOGY RESEARCH; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PATIENT SELECTION; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUESTIONNAIRE; TREATMENT OUTCOME; UNITED KINGDOM;

6-MERCAPTOPURINE; ADULT; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; AZATHIOPRINE; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG UTILIZATION REVIEW; ENGLAND; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MEDICAL STAFF, HOSPITAL; NURSE CLINICIANS; NURSING METHODOLOGY RESEARCH; PATIENT EDUCATION; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES; QUALITATIVE RESEARCH; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 34547487946     PISSN: 09621067     EISSN: 13652702     Source Type: Journal    
DOI: 10.1111/j.1365-2702.2006.01670.x     Document Type: Article

References (30)

1. Allison MC, Dhillon AP, Lewis WG Pounder RE (1998) Inflammatory Bowel Disease. Mosby Publications, London.
2. Bell J (2002) Doing Your Research Project, 3rd edn. Open University Press, Philadelphia, PA.
3. Bloomfield RS Onken JE (2003) Mercaptopurine metabolite results in clinical gastroenterology practice. Alimentary Pharmacology and Therapeutics 17, 69 73.
4. BNF (2004) BNF Online. Available at: http://www.bnf.org/ (accessed 17 May 2004).
5. Bouhnik Y, Lemann M, Mary JY, Scemama G, Tai R, Matuchansky C, Modigliani R Rambaud JC (1996) Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. The Lancet 347, 215 219.
6. Census (2001) Census Website. Available at: http://www.statistics.gov.uk/ census2001 (accessed 7 January 2003).
7. Columbel J (2000) Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 118, 1025 1030.
8. Connell WR, Kamm MA, Ritchie JK Lennard-Jones JE (1993) Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 34, 1081 1085.
9. Cuffari C, Hunt S Bayless T (2001) Utilization of erythrocyte 6-thioguinine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease. Gut 48, 642 646.
10. Cunliffe RN Scott BB (2002) Review article. Monitoring for drug side effects in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 16, 647 662.
11. DOH (2001) The Expert Patient: A New Approach to Chronic Disease Management for the 21st Century. Department of Health Publication, The stationary Office, London.
12. Fields CL, Robinson JW, Roy TM, Ossorio MA Byrd RB (1998) Hypersensitivity reaction to azathioprine. Southern Journal of Medicine 91, 471 474.
13. Forbes A (1997) Clinicians Guide to Inflammatory Bowel Disease. Chapman and Hall Medical, London.
14. Fraser AG, Orchard TR Jewell DP (2002) The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30-year review. Gut 50, 485 489.
15. Halligan A Donaldson L (2001) Implementing clinical governance: turning vision into reality. British Medical Journal 322, 1413 1417.
16. Hanauer SB (1996) Inflammatory bowel disease, drug therapy. The New England Journal of Medicine 334, 841 848.
17. Hawthorne AB (1992) Randomised control trial of azathioprine withdrawal in ulcerative colitis. British Medical Journal 305, 20 22.
18. Lichtenstein G (2003) The Clinicians Guide to Inflammatory Bowel Disease. SLACK Incorporated, Thorofare, NJ, USA.
19. McGovern DPB, Travis SPL, Duley J, Shobowale-Bakre EIM Dalton HR (2002) Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity. Gastroenterology 122, 838 839.
20. NACC (2002) NACC Website. Available at: http://www.nacc.org.uk (accessed 5 December 2005).
21. Nash CL Sutherland LR (2001) Medical management of inflammatory bowel disease: old and new perspectives. Current Opinion in Gastroenterology 17, 336 341.
22. Neilson O, Vainer B Rask-Madsen J (2001) Review article. The treatment of inflammatory bowel disease with 6-mercaptopurine and azathioprine. Alimentary Pharmacology and Therapeutics 15, 1699 1708.
23. Polit Denise F Hungler Bernadette P (1997) Essentials of Nursing Research, Methods, Appraisal and Utilization, 4th edn. Lippincott-Raven Publishers, Philadelphia.
24. Present DH, Meltzer SJ, Krumholz MP, Wolke A Korelitz BI (1989) 6-Mercaptopurine in the management of inflammatory bowel disease: short and long-term toxicity. Annals of Internal Medicine 111, 641 649.
25. Rowlinson A (1999) Inflammatory bowel disease 2: medical and surgical treatment. British Journal of Nursing 8, 926 930.
26. Rutgeerts P (2002) A critical assessment of new therapies in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 17 (Suppl. S177 S186.
27. Sands BE (2000) Therapy of inflammatory bowel disease. Gastroenterology 118, S68 S82.
28. Stack WA, Williams D, Stevenson M Logan RFA (1999) Immunosuppressive therapy for ulcerative colitis; results of a nationwide survey among consultant physician members of the British Society of Gastroenterology. Alimentary Pharmacology and Therapeutics 13, 569 575.
29. Travis S (2003) Recent advances in immunomodulation in the treatment of inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 15, 215 218.
30. Wallace TM Veldhuyzen van Zanten SJO (2001) Frequency of use and standards of care for the use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease: a systematic review of the literature and survey of Canadian gastroenterologists. Canadian Journal of Gastroenterology 15, 21 28.